Medicus Pharma Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Raza Bokhari
Chief executive officer
US$100.9k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.3yrs |
| CEO ownership | n/a |
| Management average tenure | 1.2yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
CEO
Raza Bokhari (57 yo)
Dr. Raza Bokhari, M.D., MBA, serves as Chief Executive Officer and Executive Chairman at Medicus Pharma Ltd. since September 29, 2023. Dr. Bokhari is the Managing Partner at RBx Capital LP since 2012.Dr....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | 2.3yrs | US$100.86k | no data | |
| Chief Scientific Officer and Head of R&D Program | 1.2yrs | US$491.05k | 0.34% $ 120.2k | |
| Chief Operating Officer | less than a year | no data | 0.00065% $ 226.9 | |
| Senior Vice President of Investor Relations | less than a year | no data | no data | |
| Senior Vice President of Public Relations | no data | no data | no data | |
| Chief Medical Officer | 1.2yrs | no data | 0% $ 0 | |
| Chief of Staff & Corporate Secretary | no data | no data | no data |
Experienced Management: MDCX's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | 2.3yrs | US$100.86k | no data | |
| Independent Director | less than a year | no data | 0.14% $ 49.3k | |
| Director | less than a year | no data | 7.96% $ 2.8m | |
| Independent Lead Director | 2.3yrs | US$105.26k | 0.050% $ 17.4k | |
| Independent Director | 2.3yrs | US$80.26k | 0.0050% $ 1.7k | |
| Independent Director | 2.3yrs | US$90.26k | 0% $ 0 | |
| Independent Director | 2.3yrs | US$90.26k | 0% $ 0 | |
| Independent Director | 1.6yrs | no data | 0.0050% $ 1.7k | |
| Chairman of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | less than a year | no data | 0% $ 0 |
Experienced Board: MDCX's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/16 01:37 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medicus Pharma Ltd. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kumaraguru Raja | Brookline Capital Markets |
| Jason Kolbert | D. Boral Capital LLC. |
| Jason McCarthy | Maxim Group |